C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/56 (2006.01) C12N 9/24 (2006.01) C12N 9/48 (2006.01) C12N 9/88 (2006.01) C12Q 1/34 (2006.01) C12Q 1/37 (2006.01) C12Q 1/527 (2006.01) G01N 33/86 (2006.01)
Patent
CA 2555979
The present invention is concerned with the diagnosis of coagulation and relates to a method for determining the heparin activity in a sample, where the sample is initially incubated with a heparin-modifying component, and then the heparin-dependent FXa inactivation is measured.
Klein Wolfgang
Zander Norbert
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Dade Behring Marburg Gmbh
Siemens Healthcare Diagnostics Products Gmbh
LandOfFree
Factor xa-based heparin assay using a heparin-modifying... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Factor xa-based heparin assay using a heparin-modifying..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Factor xa-based heparin assay using a heparin-modifying... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1990015